Does Eli Lilly's Future Depend on its Alzheimer's Drug?

The market has high expectations for Eli Lilly's new Alzheimer's drug.
A recent Medicare ruling on a similar rival drug undermines the future of Lilly's contender.
The drugmaker still has a promising pipeline, but keep an eye on its Alzheimer's candidate's test results.